In another study of pancreatic cancer, ALKBH5 is shown to activate PER1 in an m6A-YTHDF2-dependent manner, and induce the activation of the ATM- CHk2-p53/CDC25C signaling pathway to inhibit the growth of tumor cells (106) (Table 2). Here, YTHDF2 is linked to familial pancreatic carcinoma.